Financial - Capital Markets
Compare Stocks
2 / 10Stock Comparison
IREN vs CLSK
Revenue, margins, valuation, and 5-year total return — side by side.
Software - Application
IREN vs CLSK — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Financial - Capital Markets | Software - Application |
| Market Cap | $20.26B | $3.71B |
| Revenue (TTM) | $501M | $785M |
| Net Income (TTM) | $-16M | $-261M |
| Gross Margin | 68.3% | 41.4% |
| Operating Margin | 3.5% | -26.4% |
| Forward P/E | 149.3x | 12.9x |
| Total Debt | $964M | $824M |
| Cash & Equiv. | $565M | $43M |
IREN vs CLSK — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Nov 21 | May 26 | Return |
|---|---|---|---|
| IREN Limited (IREN) | 100 | 336.0 | +236.0% |
| CleanSpark, Inc. (CLSK) | 100 | 81.6 | -18.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: IREN vs CLSK
Each card shows where this stock fits in a portfolio — not just who wins on paper.
IREN carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- beta 2.97
- Rev growth 167.7%, EPS growth 234.5%
- 149.4% 10Y total return vs CLSK's -83.8%
CLSK is the clearest fit if your priority is value and dividends.
- Lower P/E (12.9x vs 149.3x)
- 0.2% yield; 2-year raise streak; the other pay no meaningful dividend
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 167.7% NII/revenue growth vs CLSK's 102.2% | |
| Value | Lower P/E (12.9x vs 149.3x) | |
| Quality / Margins | 17.4% margin vs CLSK's -33.2% | |
| Stability / Safety | Beta 2.97 vs CLSK's 3.39 | |
| Dividends | 0.2% yield; 2-year raise streak; the other pay no meaningful dividend | |
| Momentum (1Y) | +8.4% vs CLSK's +79.2% | |
| Efficiency (ROA) | -0.2% ROA vs CLSK's -8.5%, ROIC 0.7% vs 10.3% |
IREN vs CLSK — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
IREN vs CLSK — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
IREN leads this category, winning 3 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
CLSK is the larger business by revenue, generating $785M annually — 1.6x IREN's $501M. IREN is the more profitable business, keeping 17.4% of every revenue dollar as net income compared to CLSK's -33.2%.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $501M | $785M |
| EBITDAEarnings before interest/tax | $62M | $181M |
| Net IncomeAfter-tax profit | -$16M | -$261M |
| Free Cash FlowCash after capex | -$260M | -$1.0B |
| Gross MarginGross profit ÷ Revenue | +68.3% | +41.4% |
| Operating MarginEBIT ÷ Revenue | +3.5% | -26.4% |
| Net MarginNet income ÷ Revenue | +17.4% | -33.2% |
| FCF MarginFCF ÷ Revenue | -2.2% | -133.1% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | +11.6% |
| EPS Growth (YoY)Latest quarter vs prior year | -7.1% | -2.6% |
Valuation Metrics
CLSK leads this category, winning 4 of 4 comparable metrics.
Valuation Metrics
At 12.9x trailing earnings, CLSK trades at a 92% valuation discount to IREN's 156.4x P/E. On an enterprise value basis, CLSK's 6.7x EV/EBITDA is more attractive than IREN's 104.1x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $20.3B | $3.7B |
| Enterprise ValueMkt cap + debt − cash | $20.7B | $4.5B |
| Trailing P/EPrice ÷ TTM EPS | 156.36x | 12.95x |
| Forward P/EPrice ÷ next-FY EPS est. | 149.28x | — |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | 104.12x | 6.73x |
| Price / SalesMarket cap ÷ Revenue | 40.44x | 4.84x |
| Price / BookPrice ÷ Book value/share | 7.49x | 2.12x |
| Price / FCFMarket cap ÷ FCF | — | — |
Profitability & Efficiency
IREN leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
IREN delivers a -0.6% return on equity — every $100 of shareholder capital generates $-1 in annual profit, vs $-14 for CLSK. CLSK carries lower financial leverage with a 0.38x debt-to-equity ratio, signaling a more conservative balance sheet compared to IREN's 0.53x. On the Piotroski fundamental quality scale (0–9), IREN scores 6/9 vs CLSK's 5/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -0.6% | -13.7% |
| ROA (TTM)Return on assets | -0.2% | -8.5% |
| ROICReturn on invested capital | +0.7% | +10.3% |
| ROCEReturn on capital employed | +0.9% | +13.7% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 5 |
| Debt / EquityFinancial leverage | 0.53x | 0.38x |
| Net DebtTotal debt minus cash | $400M | $781M |
| Cash & Equiv.Liquid assets | $565M | $43M |
| Total DebtShort + long-term debt | $964M | $824M |
| Interest CoverageEBIT ÷ Interest expense | 31.42x | -18.49x |
Total Returns (Dividends Reinvested)
IREN leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in IREN five years ago would be worth $24,941 today (with dividends reinvested), compared to $8,020 for CLSK. Over the past 12 months, IREN leads with a +838.2% total return vs CLSK's +79.2%. The 3-year compound annual growth rate (CAGR) favors IREN at 164.9% vs CLSK's 50.7% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +42.8% | +25.5% |
| 1-Year ReturnPast 12 months | +838.2% | +79.2% |
| 3-Year ReturnCumulative with dividends | +1759.1% | +242.0% |
| 5-Year ReturnCumulative with dividends | +149.4% | -19.8% |
| 10-Year ReturnCumulative with dividends | +149.4% | -83.8% |
| CAGR (3Y)Annualised 3-year return | +164.9% | +50.7% |
Risk & Volatility
IREN leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
IREN is the less volatile stock with a 2.97 beta — it tends to amplify market swings less than CLSK's 3.39 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. IREN currently trades 79.3% from its 52-week high vs CLSK's 61.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 2.97x | 3.39x |
| 52-Week HighHighest price in past year | $76.87 | $23.61 |
| 52-Week LowLowest price in past year | $6.01 | $7.82 |
| % of 52W HighCurrent price vs 52-week peak | +79.3% | +61.4% |
| RSI (14)Momentum oscillator 0–100 | 65.4 | 66.4 |
| Avg Volume (50D)Average daily shares traded | 34.1M | 19.0M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Wall Street rates IREN as "Buy" and CLSK as "Buy". Consensus price targets imply 39.4% upside for CLSK (target: $20) vs 23.9% for IREN (target: $76). CLSK is the only dividend payer here at 0.23% yield — a key consideration for income-focused portfolios.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $75.57 | $20.21 |
| # AnalystsCovering analysts | 13 | 10 |
| Dividend YieldAnnual dividend ÷ price | — | +0.2% |
| Dividend StreakConsecutive years of raises | — | 2 |
| Dividend / ShareAnnual DPS | — | $0.03 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +3.9% |
IREN leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). CLSK leads in 1 (Valuation Metrics).
IREN vs CLSK: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is IREN or CLSK a better buy right now?
For growth investors, IREN Limited (IREN) is the stronger pick with 167.
7% revenue growth year-over-year, versus 102. 2% for CleanSpark, Inc. (CLSK). CleanSpark, Inc. (CLSK) offers the better valuation at 12. 9x trailing P/E, making it the more compelling value choice. Analysts rate IREN Limited (IREN) a "Buy" — based on 13 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — IREN or CLSK?
On trailing P/E, CleanSpark, Inc.
(CLSK) is the cheapest at 12. 9x versus IREN Limited at 156. 4x.
03Which is the better long-term investment — IREN or CLSK?
Over the past 5 years, IREN Limited (IREN) delivered a total return of +149.
4%, compared to -19. 8% for CleanSpark, Inc. (CLSK). Over 10 years, the gap is even starker: IREN returned +149. 4% versus CLSK's -83. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — IREN or CLSK?
By beta (market sensitivity over 5 years), IREN Limited (IREN) is the lower-risk stock at 2.
97β versus CleanSpark, Inc. 's 3. 39β — meaning CLSK is approximately 14% more volatile than IREN relative to the S&P 500. On balance sheet safety, CleanSpark, Inc. (CLSK) carries a lower debt/equity ratio of 38% versus 53% for IREN Limited — giving it more financial flexibility in a downturn.
05Which is growing faster — IREN or CLSK?
By revenue growth (latest reported year), IREN Limited (IREN) is pulling ahead at 167.
7% versus 102. 2% for CleanSpark, Inc. (CLSK). On earnings-per-share growth, the picture is similar: CleanSpark, Inc. grew EPS 262. 3% year-over-year, compared to 234. 5% for IREN Limited. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — IREN or CLSK?
CleanSpark, Inc.
(CLSK) is the more profitable company, earning 47. 6% net margin versus 17. 4% for IREN Limited — meaning it keeps 47. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CLSK leads at 41. 6% versus 3. 5% for IREN. At the gross margin level — before operating expenses — IREN leads at 68. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is IREN or CLSK more undervalued right now?
Analyst consensus price targets imply the most upside for CLSK: 39.
4% to $20. 21.
08Which pays a better dividend — IREN or CLSK?
In this comparison, CLSK (0.
2% yield) pays a dividend. IREN does not pay a meaningful dividend and should not be held primarily for income.
09Is IREN or CLSK better for a retirement portfolio?
For long-horizon retirement investors, IREN Limited (IREN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (+149.
4% 10Y return). CleanSpark, Inc. (CLSK) carries a higher beta of 3. 39 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (IREN: +149. 4%, CLSK: -83. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between IREN and CLSK?
These companies operate in different sectors (IREN (Financial Services) and CLSK (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.